PRELIMINARY PROGRAM
The program may be subject to change


Wednesday March 29, 9.00-12.00 - Pre-Course
Johan Zelano and Francesco Brigo

Conference room: Europa

09.00-09.15 Welcome


09.15-10.00 Diagnosis of epilepsy in the context of other brain disease: application of the ILAE definition 


10.00-10.30 Coffee break 


10.30-11.15 Management of a seizures of different etiologies: stroke, TBI, CNS infections. What evidence is there? 


11.15-12.00 Epidemiology of different acquired epilepsies – an introduction. 


12.00 Lunch



Wednesday March 29, 13.00-17.00 - STESS conference

Conference room: Wallenbergsalen

Session 1: Preclinical / epileptogenesis / disease modification

13.00-13.10 Opening remarks
Francesco Brigo and Johan Zelano


13.10-13.50  The immune system in epileptogenesis
Alberto Vogrig, Italy


13.50-14.30 Mechanisms of epileptogenesis in preclinical studies 
Emilio Russo, Italy


14.30-15.00 Coffee break


15.00-15.40 Modulating epileptogenesis: past and present human trials
Eugen Trinka, Austria 


15.40-16.20  Is there familial vulnerability for symptomatic epilepsies?
Jakob Christensen, Denmark


16.20-17.00  Platform session 
3x15 min presentations.


17.00-17.45 Sponsored symposium


17.45-19.00 Welcome reception
Hosted by the City of Gothenburg and Region Västra Götaland
  


Thursday March 30 - STESS Conference

Session 2: Risk factors and biomarkers

09.00-09.40 The value of EEG as biomarker of epileptogenesis and seizures recurrence in different acquired epilepsies
Carla Bentes, Portugal


09.40-10.20 Reperfusion therapies and the risk of poststroke epilepsy 
Petra Redfors, Sweden


10.20-10.50 Coffee break


10.50-11.30  The immune reaction as a potential biomarker in epilepsy
Christine Ekdahl, Sweden


11.30-12.00 Platform session 
2x15 min presentations


12.00-12.30  Lunch


12.30-13.25 Sponsored lunch symposium, Eisai


Session 3: Diagnosis, treatment and prognosis

13.25-14.05  Serum biomarkers for the diagnosis of structural acquired epilepsies
Laura Abraira, Spain


14.05-14.35  Tailored ASM selection in acquired epilepsy based on big data
Johan Zelano, Sweden


14.35-15.00 Coffee break


15.00-15.40 Predicting treatment resistance in acquired epilepsies
Simona Lattanzi, Italy


15.40-16.20 Prognosis of symptomatic epilepsies: the impact on survival
Rob Rouhl, The Netherlands


16.20-17.10 Platform session
3x15 min presentations


Friday March 31 - STESS Conference

Session 4: Prognosis continued, Hot topics 

09.00-09.40 Drug withdrawal in structural and symptomatic epilepsies
Morten Lossius, Norway


09.40-10.20 Epilepsy surgery for symptomatic epilepsies
Reetta Kälviäinen, Finland 


10.20-10.50 Coffee break


10.50-11.30  Seizures in and after brain infections
Ley Sander, UCL, UK. 


11.30-12.00  NORSE and FIRES in adults and children - Do we need to think differently? 

Ronny Wickström, Sweden


12.00-12.15  Closing remarks 
Johan Zelano and Francesco Brigo


12.15  Lunch


Last update: 2022-12-03